A Dorevitch

664 total citations
21 papers, 489 citations indexed

About

A Dorevitch is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Geriatrics and Gerontology. According to data from OpenAlex, A Dorevitch has authored 21 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Psychiatry and Mental health, 5 papers in Pediatrics, Perinatology and Child Health and 5 papers in Geriatrics and Gerontology. Recurrent topics in A Dorevitch's work include Schizophrenia research and treatment (6 papers), Bipolar Disorder and Treatment (5 papers) and Epilepsy research and treatment (5 papers). A Dorevitch is often cited by papers focused on Schizophrenia research and treatment (6 papers), Bipolar Disorder and Treatment (5 papers) and Epilepsy research and treatment (5 papers). A Dorevitch collaborates with scholars based in Israel. A Dorevitch's co-authors include A Lerner, Boris Finkel, Ronnen H. Segman, Bernard Lerer, Uriel Heresco‐Levy, A Yakir, Zvi Zemishlany, Abraham Weizman, Nachum Katz and Dov Aizenberg and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Molecular Psychiatry.

In The Last Decade

A Dorevitch

21 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A Dorevitch Israel	11	321	93	68	62	62	21	489
P. J. Perry United States	12	526 1.6×	138 1.5×	93 1.4×	66 1.1×	22 0.4×	20	872
Chay‐Hoon Tan Singapore	14	270 0.8×	40 0.4×	39 0.6×	23 0.4×	46 0.7×	24	592
C. Stuppaeck Austria	14	343 1.1×	62 0.7×	55 0.8×	92 1.5×	18 0.3×	23	637
Jessica L. Gören United States	14	484 1.5×	43 0.5×	119 1.8×	69 1.1×	20 0.3×	28	719
Matthew A. Fuller United States	18	570 1.8×	51 0.5×	95 1.4×	61 1.0×	25 0.4×	52	835
Silvia Paletta Italy	12	382 1.2×	96 1.0×	112 1.6×	55 0.9×	11 0.2×	29	673
L. G. Schmidt Germany	10	165 0.5×	93 1.0×	35 0.5×	31 0.5×	15 0.2×	20	370
Mark D. Watanabe United States	7	252 0.8×	33 0.4×	84 1.2×	45 0.7×	18 0.3×	11	414
Bruce L. Saltz United States	13	912 2.8×	121 1.3×	132 1.9×	50 0.8×	37 0.6×	15	1.2k
Robert L. Dufresne United States	14	487 1.5×	61 0.7×	38 0.6×	58 0.9×	10 0.2×	33	720

Countries citing papers authored by A Dorevitch

Since Specialization

Citations

This map shows the geographic impact of A Dorevitch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Dorevitch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Dorevitch more than expected).

Fields of papers citing papers by A Dorevitch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Dorevitch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Dorevitch. The network helps show where A Dorevitch may publish in the future.

Co-authorship network of co-authors of A Dorevitch

This figure shows the co-authorship network connecting the top 25 collaborators of A Dorevitch. A scholar is included among the top collaborators of A Dorevitch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Dorevitch. A Dorevitch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Segman, Ronnen H., Uriel Heresco‐Levy, Boris Finkel, et al.. (2001). Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia. Molecular Psychiatry. 6(2). 225–229. 117 indexed citations

Segman, Ronnen H., Uriel Heresco‐Levy, Boris Finkel, et al.. (1999). Genotypic association between the dopamine D3 receptor and tardive dyskinesia in chronic schizophrenia. Molecular Psychiatry. 4(3). 247–253. 120 indexed citations

Dorevitch, A, et al.. (1997). Lack of effect of vitamin E on serum creatine phosphokinase in patients with long-term tardive dyskinesia. International Clinical Psychopharmacology. 12(3). 171–174. 9 indexed citations

Dorevitch, A, et al.. (1997). Treatment long-term tardive dyskinesia with vitamin E. Biological Psychiatry. 41(1). 114–116. 27 indexed citations

Dorevitch, A, et al.. (1996). The impact of clinical pharmacy intervention in a psychiatric hospital. Journal of Clinical Pharmacy and Therapeutics. 21(1). 45–48. 22 indexed citations

Dorevitch, A, et al.. (1996). The impact of clinical pharmacy intervention in a psychiatric hospital. Journal of Clinical Pharmacy and Therapeutics. 21(1). 45–48. 12 indexed citations

Dorevitch, A, et al.. (1995). Antipsychotic drugs and tardive dyskinesia: preliminary results in an adolescent psychiatric ward. Journal of Clinical Pharmacy and Therapeutics. 20(2). 63–65. 5 indexed citations

Dorevitch, A, et al.. (1994). Fluvoxamine-Associated Sexual Dysfunction. Annals of Pharmacotherapy. 28(7-8). 872–874. 21 indexed citations

Dorevitch, A. (1994). A psychopharmacology education program for psychiatry residents--the role of a clinical pharmacist.. PubMed. 31(4). 287–91. 5 indexed citations

10.

Dorevitch, A, et al.. (1994). [Lithium-associated psoriasis].. PubMed. 127(7-8). 228–9, 287. 2 indexed citations

11.

Durst, Rimona, et al.. (1993). Idiopathic Unconjugated Hyperbilirubinemia (Gilbert's Syndrome) and Concurrent Psychotropic Drug Administration. Pharmacopsychiatry. 26(2). 49–52. 8 indexed citations

12.

Dorevitch, A, et al.. (1993). Medication maintenance of chronic schizophrenic out–patients by a psychiatric clinical pharmacist: 10–year follow–up study. Journal of Clinical Pharmacy and Therapeutics. 18(3). 183–186. 24 indexed citations

13.

Durst, Rimona, et al.. (1993). Platelet Dysfunction Associated With Clozapine Therapy. Southern Medical Journal. 86(10). 1170–1172. 10 indexed citations

14.

Dorevitch, A, et al.. (1993). Fluvoxamine-Associated Manic Behavior: A Case Series. Annals of Pharmacotherapy. 27(12). 1455–1457. 11 indexed citations

15.

Dorevitch, A, et al.. (1991). Psychotic exacerbation attributed to low‐dose bromocriptine treatment of galactorrhea and hyperprolactinemia. Acta Obstetricia Et Gynecologica Scandinavica. 70(4-5). 375–376. 20 indexed citations

16.

Dorevitch, A, Rimona Durst, & Y Ginath. (1991). Propranolol in the Treatment of Akathisia Caused by Antipsychotic Drugs. Southern Medical Journal. 84(12). 1505–1506. 4 indexed citations

17.

Dorevitch, A. (1991). Mania Associated with Clonazepam. DICP. 25(9). 938–939. 3 indexed citations

18.

Durst, Rimona, et al.. (1990). [Bromocriptine-associated postpartum psychotic exacerbation].. PubMed. 118(4). 203–4. 5 indexed citations

19.

Dorevitch, A & Frances H. Gabbay. (1984). Neuroleptic-associated catatonic reaction.. PubMed. 2(6). 581–2. 2 indexed citations

20.

Dorevitch, A, et al.. (1981). Rational Use of Psychoactive Drugs in the Geriatric Patient. Drug Intelligence & Clinical Pharmacy. 15(12). 940–944. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact